Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Change in Account Payables came in at -$733000.0 in Q1 2026, down 128.13% YoY from $2.6 million in Q1 2025, and down 145.08% on a QoQ basis from $1.6 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Change in Account Payables (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Change in Account Payables data on file, last reported at -$733000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 128.13% year-over-year to -$733000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 17.22% YoY) and the FY2025 annual result came in at $8.1 million, up 183.26% from the prior year.
- Change in Account Payables fell to -$733000.0 in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.5 million in Q1 2022 to a low of -$11.1 million in Q1 2024.
- A 5-year average of $288294.1 and a median of $637000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables soared 4042.42% — and 2024, when it slumped 485.42%.
- Tracing KOD's Change in Account Payables over 5 years: stood at -$5.4 million in 2022, then jumped by 145.74% to $2.5 million in 2023, then plunged by 74.35% to $637000.0 in 2024, then surged by 155.26% to $1.6 million in 2025, then sank by 145.08% to -$733000.0 in 2026.
- The last three Change in Account Payables figures came in at -$733000.0 (Q1 2026), $1.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | 982,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 982,000.00 |
| Mar 31, 2026 | -733,000.00 |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | 2.61 Mn |
| Dec 31, 2024 | 637,000.00 |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | -791,000.00 |
| Mar 31, 2024 | -11.12 Mn |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | -435,000.00 |
| Jun 30, 2023 | 5.45 Mn |
| Mar 31, 2023 | -1.90 Mn |
| Dec 31, 2022 | -5.43 Mn |
| Sep 30, 2022 | -5.78 Mn |
| Jun 30, 2022 | 6.36 Mn |
| Mar 31, 2022 | 6.51 Mn |
| Dec 31, 2021 | -5.35 Mn |
| Sep 30, 2021 | 9.01 Mn |